Each quarter, Asa provides updates on notable FDA warning letters and enforcement trends. Understanding enforcement trends is essential for being a savvy marketer, regulatory affairs professional or dietary supplement executive. Have you wondered why FDA issues warning letters to certain companies and not others? FDA likes to make examples of companies not following the rules in areas they want to focus on, many of which Asa reviews here. Staying ahead of trouble is one of the critical and fun reasons to follow enforcement trends.

2024 has been noticeably light in dietary supplement warning letters, and I don’t have a good guess as to why. Dozens of companies continue to make extreme disease claims — such as the treatment, prevention or mitigation of cancer — about their products or ingredients. I expect more regulatory action in the months to come.

Read More for Asa's 2025 Predictions.